BRPI0920082A2 - forma de dosagem oral de acetaminofeno/tramadol com liberação estendida. - Google Patents

forma de dosagem oral de acetaminofeno/tramadol com liberação estendida.

Info

Publication number: BRPI0920082A2
Authority: BR; Brazil
Prior art keywords: tramadol; dosage form; oral dosage; extended release; release acetaminophen
Prior art date: 2008-10-27

Application number

BRPI0920082A

Other languages

English (en)

Inventor

Ho Lee Domg

Hyun Kim Jae

Dong Liang-Chang

Joo Hwang Sung

Choi Tae-Hong

Wei-Guo-Dai

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-27

Filing date

2009-10-23

Publication date

2019-09-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41514164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0920082(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-10-23 Application filed by Alza Corp filed Critical Alza Corp

2019-09-24 Publication of BRPI0920082A2 publication Critical patent/BRPI0920082A2/pt

Links

229940056133 acetaminophen / tramadol Drugs 0.000 title 1
238000013265 extended release Methods 0.000 title 1
239000006186 oral dosage form Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

BRPI0920082A 2008-10-27 2009-10-23 forma de dosagem oral de acetaminofeno/tramadol com liberação estendida. BRPI0920082A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10861808P	2008-10-27	2008-10-27
PCT/US2009/061803 WO2010062524A1 (en)	2008-10-27	2009-10-23	Extended release oral acetaminophen/tramadol dosage form

Publications (1)

Publication Number	Publication Date
BRPI0920082A2 true BRPI0920082A2 (pt)	2019-09-24

Family

ID=41514164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0920082A BRPI0920082A2 (pt)	2008-10-27	2009-10-23	forma de dosagem oral de acetaminofeno/tramadol com liberação estendida.

Country Status (25)

Country	Link
US (1)	US20100104638A1 (pt)
EP (1)	EP2362768B1 (pt)
JP (1)	JP5713911B2 (pt)
KR (3)	KR20110119845A (pt)
CN (2)	CN102264355A (pt)
AU (1)	AU2009320181B2 (pt)
BR (1)	BRPI0920082A2 (pt)
CA (1)	CA2741751C (pt)
CL (1)	CL2011000935A1 (pt)
CO (1)	CO6331423A2 (pt)
CR (1)	CR20110287A (pt)
EA (1)	EA023149B1 (pt)
EC (1)	ECSP11011009A (pt)
ES (1)	ES2582779T3 (pt)
HN (1)	HN2011001184A (pt)
IL (1)	IL212453A (pt)
MX (1)	MX339867B (pt)
MY (1)	MY161550A (pt)
NI (1)	NI201100079A (pt)
NZ (1)	NZ592325A (pt)
PE (1)	PE20110855A1 (pt)
TW (1)	TWI561257B (pt)
UA (1)	UA102706C2 (pt)
WO (1)	WO2010062524A1 (pt)
ZA (1)	ZA201103880B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5774853B2 (ja)	2008-01-25	2015-09-09	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	医薬投薬形
MX2010012039A (es)	2008-05-09	2010-11-30	Gruenenthal Gmbh	Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
BR112012001547A2 (pt)	2009-07-22	2016-03-08	Gruenenthal Gmbh	forma de dosagem farmacêutica extrusada por fusão a quente
ES2428938T3 (es)	2009-07-22	2013-11-12	Grünenthal GmbH	Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
CN103179954A (zh)	2010-09-02	2013-06-26	格吕伦塔尔有限公司	包含阴离子聚合物的抗破碎剂型
CA2808219C (en)	2010-09-02	2019-05-14	Gruenenthal Gmbh	Tamper resistant dosage form comprising inorganic salt
WO2012154563A1 (en) *	2011-05-06	2012-11-15	Glaxosmithkline Llc	Sustained release paracetamol formulations
US10702485B2 (en)	2011-07-09	2020-07-07	Syntrix Biosystems Inc.	Compositions and methods for overcoming resistance to tramadol
CA2839123A1 (en)	2011-07-29	2013-02-07	Grunenthal Gmbh	Tamper-resistant tablet providing immediate drug release
PL2736497T3 (pl)	2011-07-29	2018-01-31	Gruenenthal Gmbh	Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
MX356421B (es)	2012-02-28	2018-05-29	Gruenenthal Gmbh	Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
PL2838512T3 (pl)	2012-04-18	2018-12-31	Grünenthal GmbH	Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
WO2013169977A2 (en) *	2012-05-10	2013-11-14	Fmc Corporation	Controlled release solid dose form
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
DE102013009114A1 (de)	2013-05-29	2014-12-04	Franz Gerstheimer	Pharmazeutische Zusammensetzung zur Überwindung von Metabolisierungsproblemen
WO2014191396A1 (en)	2013-05-29	2014-12-04	Grünenthal GmbH	Tamper resistant dosage form with bimodal release profile
MX371432B (es)	2013-05-29	2020-01-30	Gruenenthal Gmbh	Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
US10624862B2 (en)	2013-07-12	2020-04-21	Grünenthal GmbH	Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
IN2013MU03098A (pt) *	2013-09-30	2015-07-17	Athena Drug Delivery Solutions Pvt Ltd
WO2015078891A1 (en)	2013-11-26	2015-06-04	Farmaceutici Formenti S.P.A.	Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3079668A1 (en)	2013-12-09	2016-10-19	Durect Corporation	Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
AU2014365038B2 (en) *	2013-12-16	2019-09-12	Grünenthal GmbH	Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion
US20150320690A1 (en)	2014-05-12	2015-11-12	Grünenthal GmbH	Tamper resistant immediate release capsule formulation comprising tapentadol
EP3148512A1 (en)	2014-05-26	2017-04-05	Grünenthal GmbH	Multiparticles safeguarded against ethanolic dose-dumping
BR112017021475A2 (pt)	2015-04-24	2018-07-10	Gruenenthal Gmbh	forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
AU2016319203A1 (en)	2015-09-10	2018-02-22	Grünenthal GmbH	Protecting oral overdose with abuse deterrent immediate release formulations
GB2567493B (en)	2017-10-13	2019-12-18	Altus Formulation Inc	Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
ES2913642T3 (es) *	2017-10-13	2022-06-03	Altus Formulation Inc	Excipientes modificadores de la liberación a base de almidón y composiciones farmacéuticas derivadas de los mismos
US11000488B2 (en)	2019-03-22	2021-05-11	Syntrix Biosystems Inc.	Treating pain using desmetramadol
KR20240027436A (ko) *	2022-08-23	2024-03-04	대원제약주식회사	펠루비프로펜 및 트라마돌의 이온결합 화합물, 이를 포함하는 조성물, 및 이의 제조 방법
KR20240158668A (ko) *	2023-04-27	2024-11-05	대원제약주식회사	펠루비프로펜 및 트라마돌을 포함하는 진통용 약학적 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS58206751A (ja) *	1982-05-26	1983-12-02	日石三菱株式会社	創傷被覆材
DE122004000032I2 (de) *	1991-09-06	2006-02-09	Mcneilab Inc	Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung
CA2173818A1 (fr) *	1996-04-10	1997-10-11	Francois Chouinard	Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
US6375957B1 (en) *	1997-12-22	2002-04-23	Euro-Celtique, S.A.	Opioid agonist/opioid antagonist/acetaminophen combinations
EP1555022B1 (en)	2002-09-21	2008-02-20	Shuyi Zhang	Sustained release formulation of acetaminophen and tramadol
UA84277C2 (ru) *	2002-10-25	2008-10-10	Лабофарм Инк.	Композиция трамадола с пролонгированным высвобождением с 24-часовым действием
WO2006053012A2 (en) *	2004-11-10	2006-05-18	Trinity Laboratories, Inc.	Novel pharmaceutical compositions for treating acquired chronic pain and associated dysphoria
AU2006269225B2 (en) *	2005-07-07	2011-10-06	Farnam Companies, Inc.	Sustained release pharmaceutical compositions for highly water soluble drugs
JP2009507047A (ja) *	2005-09-09	2009-02-19	ラボファームインコーポレイテッド	持続性薬物放出組成物
CN1785167A (zh) *	2005-10-08	2006-06-14	王鸣	一种非麻醉性镇痛剂的复方缓释制剂的制备方法
DE102006056458A1 (de) *	2006-11-28	2008-05-29	Grünenthal GmbH	Arzneimittelzubereitung von Tramadol und Acetaminophen
AR067602A1 (es) *	2007-07-18	2009-10-14	Janssen Pharmaceutica Nv	Sulfonamida como moduladores del trpm8
CN101969930A (zh) *	2007-12-17	2011-02-09	莱博法姆公司	防滥用控制释放制剂
AU2009223061B2 (en) *	2008-03-11	2014-10-09	Depomed Inc.	Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

2009
- 2009-10-23 MX MX2011004403A patent/MX339867B/es active IP Right Grant
- 2009-10-23 UA UAA201106620A patent/UA102706C2/ru unknown
- 2009-10-23 KR KR1020117024463A patent/KR20110119845A/ko not_active Ceased
- 2009-10-23 JP JP2011534641A patent/JP5713911B2/ja not_active Expired - Fee Related
- 2009-10-23 CN CN2009801536507A patent/CN102264355A/zh active Pending
- 2009-10-23 EP EP09740619.3A patent/EP2362768B1/en active Active
- 2009-10-23 CN CN201610873739.2A patent/CN107028908A/zh active Pending
- 2009-10-23 KR KR1020137031476A patent/KR101631140B1/ko not_active Expired - Fee Related
- 2009-10-23 WO PCT/US2009/061803 patent/WO2010062524A1/en not_active Ceased
- 2009-10-23 CA CA2741751A patent/CA2741751C/en not_active Expired - Fee Related
- 2009-10-23 BR BRPI0920082A patent/BRPI0920082A2/pt not_active IP Right Cessation
- 2009-10-23 MY MYPI2011001827A patent/MY161550A/en unknown
- 2009-10-23 KR KR1020117004791A patent/KR20110036858A/ko not_active Ceased
- 2009-10-23 AU AU2009320181A patent/AU2009320181B2/en not_active Ceased
- 2009-10-23 US US12/604,560 patent/US20100104638A1/en not_active Abandoned
- 2009-10-23 PE PE2011000940A patent/PE20110855A1/es not_active Application Discontinuation
- 2009-10-23 NZ NZ592325A patent/NZ592325A/xx not_active IP Right Cessation
- 2009-10-23 EA EA201170616A patent/EA023149B1/ru not_active IP Right Cessation
- 2009-10-23 ES ES09740619.3T patent/ES2582779T3/es active Active
- 2009-10-26 TW TW098136097A patent/TWI561257B/zh not_active IP Right Cessation
2011
- 2011-04-26 CO CO11050889A patent/CO6331423A2/es not_active Application Discontinuation
- 2011-04-26 IL IL212453A patent/IL212453A/en not_active IP Right Cessation
- 2011-04-26 CL CL2011000935A patent/CL2011000935A1/es unknown
- 2011-04-27 EC EC2011011009A patent/ECSP11011009A/es unknown
- 2011-04-27 NI NI201100079A patent/NI201100079A/es unknown
- 2011-04-27 HN HN2011001184A patent/HN2011001184A/es unknown
- 2011-05-26 ZA ZA2011/03880A patent/ZA201103880B/en unknown
- 2011-05-27 CR CR20110287A patent/CR20110287A/es unknown

Also Published As

Publication number	Publication date
EA201170616A1 (ru)	2011-12-30
HK1162915A1 (zh)	2012-09-07
JP2012506907A (ja)	2012-03-22
CA2741751C (en)	2017-05-09
KR20110036858A (ko)	2011-04-11
KR20110119845A (ko)	2011-11-02
CR20110287A (es)	2011-11-10
AU2009320181B2 (en)	2015-08-27
EP2362768A1 (en)	2011-09-07
MX2011004403A (es)	2011-05-25
KR101631140B1 (ko)	2016-06-20
MY161550A (en)	2017-04-28
UA102706C2 (ru)	2013-08-12
ZA201103880B (en)	2012-10-31
EA023149B1 (ru)	2016-04-29
WO2010062524A1 (en)	2010-06-03
NI201100079A (es)	2011-10-21
HN2011001184A (es)	2014-09-01
TWI561257B (en)	2016-12-11
CA2741751A1 (en)	2010-06-03
ECSP11011009A (es)	2011-06-30
AU2009320181A1 (en)	2010-06-03
CO6331423A2 (es)	2011-10-20
JP5713911B2 (ja)	2015-05-07
KR20130137720A (ko)	2013-12-17
CN107028908A (zh)	2017-08-11
IL212453A0 (en)	2011-06-30
TW201028180A (en)	2010-08-01
NZ592325A (en)	2012-09-28
US20100104638A1 (en)	2010-04-29
EP2362768B1 (en)	2016-04-20
PE20110855A1 (es)	2011-12-05
CL2011000935A1 (es)	2011-10-21
IL212453A (en)	2017-03-30
CN102264355A (zh)	2011-11-30
MX339867B (es)	2016-06-14
ES2582779T3 (es)	2016-09-15

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0920082A2 (pt)	2019-09-24	forma de dosagem oral de acetaminofeno/tramadol com liberação estendida.
CY2018030I2 (el)	2019-11-27	Φαρμακοτεχνικη μορφη 514
BRPI1012004A2 (pt)	2016-05-10	"forma farmacêutica"
BRPI0920521A2 (pt)	2018-01-16	combinação farmacêutica
DK2265144T3 (da)	2019-10-14	Pensel
BRPI0819231A2 (pt)	2015-05-05	Forma de dosagem de desintegração oral
BRPI0822722A2 (pt)	2015-07-07	Implemento para cuidado oral.
EP2263545A4 (en)	2011-05-04	sonographer
BRPI0906802A2 (pt)	2015-07-14	Implemento para cuidado oral.
SMT201700095B (is)	2017-03-08	Composizioni farmaceutiche per inalazione
NO20083238L (no)	2010-01-25	Narresmokk
PL2379086T3 (pl)	2016-01-29	Preparat farmeceutyczny
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
BRPI0922806A2 (pt)	2015-12-22	formas de dosagem oral de bendamustina
DK2271618T3 (da)	2014-06-16	Farmaceutiske forbindelser
BRPI0807882A2 (pt)	2014-06-17	Forma de dosagem
BRPI0812964A2 (pt)	2014-12-16	Forma de dosagem farmacêutica oral sólida
PT2271348T (pt)	2018-04-16	Formulação de comprimido oral de composto de tetraciclina
BRPI0912171A2 (pt)	2017-10-31	composição farmacêutica
EP2283352A4 (en)	2012-03-14	Acetaminophen TEST PROCEDURE
BRPI1007237A2 (pt)	2016-02-16	composição farmacêutica compreendendo aleglitazar
DK2271321T3 (da)	2012-08-27	Farmaceutisk sammensætning 271
BRPI0921301A2 (pt)	2015-12-29	composição farmacêutica